Atria Investments’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.48M Sell
6,769
-471
-7% -$103K 0.02% 856
2025
Q1
$1.62M Sell
7,240
-1,428
-16% -$320K 0.02% 788
2024
Q4
$2.84M Sell
8,668
-406
-4% -$133K 0.04% 548
2024
Q3
$2.72M Buy
9,074
+1,475
+19% +$443K 0.03% 567
2024
Q2
$2.5M Sell
7,599
-436
-5% -$144K 0.03% 569
2024
Q1
$3.18M Sell
8,035
-617
-7% -$244K 0.04% 485
2023
Q4
$3.05M Sell
8,652
-1,119
-11% -$394K 0.05% 442
2023
Q3
$3.67M Buy
9,771
+338
+4% +$127K 0.07% 361
2023
Q2
$3.61M Buy
9,433
+157
+2% +$60K 0.07% 358
2023
Q1
$3.21M Buy
9,276
+669
+8% +$232K 0.06% 374
2022
Q4
$2.03M Buy
8,607
+2,589
+43% +$609K 0.04% 505
2022
Q3
$1.48M Sell
6,018
-913
-13% -$225K 0.03% 584
2022
Q2
$2.1M Sell
6,931
-7,271
-51% -$2.2M 0.04% 493
2022
Q1
$5.83M Buy
14,202
+421
+3% +$173K 0.1% 234
2021
Q4
$6.46M Buy
13,781
+1,154
+9% +$541K 0.12% 215
2021
Q3
$5.36M Buy
12,627
+1,835
+17% +$779K 0.1% 230
2021
Q2
$3.88M Sell
10,792
-493
-4% -$177K 0.07% 300
2021
Q1
$3.18M Buy
11,285
+6,415
+132% +$1.81M 0.07% 322
2020
Q4
$1.38M Sell
4,870
-14,912
-75% -$4.23M 0.03% 550
2020
Q3
$5.44M Buy
+19,782
New +$5.44M 0.17% 144
2020
Q1
Sell
-3,763
Closed -$566K 1209
2019
Q4
$566K Buy
3,763
+489
+15% +$73.6K 0.02% 735
2019
Q3
$464K Buy
+3,274
New +$464K 0.02% 605